Cholesterol synthesis and absorption in coronary patients with lipid triad and isolated high LDL cholesterol in a 4S subgroup


      We assumed that assaying serum cholesterol precursors (synthesis markers) and plant sterols and cholestanol (absorption markers of cholesterol) reveals differences in cholesterol synthesis and absorption in the Finnish 4S subgroup divided in high triglyceride-low HDL cholesterol (lipid triad=HTG) and isolated high LDL cholesterol (ILDL) groups. Serum squalene and non-cholesterol sterol ratios to cholesterol were measured with gas-liquid chromatography at baseline, 6 weeks, 1 year, and 5 years on simvastatin. Patients with HTG (n=135) exhibited features of metabolic syndrome and, in spite of similar serum total and LDL cholesterol levels, ratios of synthesis markers were higher and those of absorption markers lower than in ILDL (n=133). The latter patients accumulated to a subgroup shown earlier to be clinical non-responders to simvastatin in 4S. Serum cholesterol reduction by simvastatin only tended to be higher in HTG than ILDL. The synthesis marker ratios were markedly reduced, and more effectively in HTG than ILDL, while the absorption marker ratios were increased, and for plant sterols more in ILDL than HTG. In conclusion, HTG is associated with high synthesis and low absorption of cholesterol, these events being opposite in ILDL. Synthesis is more effectively reduced by simvastatin in HTG than ILDL in spite of similar reduction in serum cholesterol. Patients defined by highest baseline absorption marker ratios in ILDL group are poor coronary event-reducers on regular simvastatin treatment.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Scandinavian Simvastatin Survival Study Group
        Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
        Lancet. 1994; 344: 1383-1389
        • Ballantyne C.M.
        • Olsson A.G.
        • Cook T.J.
        • et al.
        Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
        Circulation. 2001; 104: 3046-3051
        • Miettinen T.A.
        • Gylling H.
        • Strandberg T.
        • Sarna S.
        Baseline serum cholestanol predicts recurrent coronary events in a subgroup of the Scandinavian Simvastatin Survival Study (4S).
        Br. Med. J. 1998; 316: 1127-1130
        • Miettinen T.A.
        • Strandberg T.E.
        • Gylling H.
        Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Relation to basal serum cholestanol.
        Arterioscler Thromb Vasc Biol. 2000; 20: 1340-1346
        • Miettinen T.A.
        Cholesterol production in obesity.
        Circulation. 1974; 44: 842-850
        • Simonen P.
        • Gylling H.
        • Howard A.N.
        • Miettinen T.A.
        Introducing a new component of the metabolic syndrome: low cholesterol absorption.
        Am J Clin Nutr. 2000; 72: 82-88
        • Andersen E.
        • Hellstöm P.
        • Hellström K.
        Cholesterol and bile acid metabolismin middle-aged diabetics.
        Diabete Metab. 1986; 12: 261-266
        • Miettinen T.A.
        • Koivisto P.
        Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass.
        in: Paumgartner G. Stiehl A. Gerok W. Bile Acids and Cholesterol in Health and Disease. MTP Press, Lancaster PA1983: 183-187
        • Miettinen T.A.
        • Tilvis R.S.
        • Kesäniemi Y.A.
        Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population.
        Am. J. Epidemiol. 1990; 131: 20-31
        • Miettinen T.A.
        • Tilvis R.S.
        • Kesäniemi Y.A.
        Serum cholestanol and plan sterol levels in relation to cholesterol metabolism in middle-aged men.
        Metabolism. 1998; 38: 136-140
        • Björkhem I.
        • Boberg K.M.
        • Leitersdorf E.
        Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol.
        in: Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease. 8th edition. McGraw-Hill, New York2001: 2961-2988
      1. Miettinen TA, Gylling H. ABCG5/8 genes responsible for serum plant sterol increase during statin treatment. In: Drugs Affecting Lipid Metabolism, New York, New York, (USA) Septmeber 9–12, 2001.

        • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
        Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
        J. Am. Med. Assoc. 2001; 285: 2486-2487
        • Ballantyne C.M.
        • Herd J.A.
        • Ferlic L.L.
        • et al.
        Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.
        Circulation. 1999; 99: 736-743
        • Robins S.J.
        • Collins D.
        • Wittes J.T.
        • et al.
        Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
        J. Am. Med. Assoc. 2001; 285: 1585-1591
        • Manninen V.
        • Tenkanen L.
        • Koskinen P.
        • et al.
        Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment.
        Circulation. 1992; 85: 37-45
        • The BIP Study Group
        Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) Study.
        Circulation. 2000; 102: 21-27
        • Heart Protection Study Collaborative Group
        MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial.
        Lancet. 2002; 366660: 7-22
        • Miettinen T.A.
        Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis.
        Eur J Clin Invest. 1980; 10: 27-35
        • Berge K.E.
        • Tian H.
        • Graf G.A.
        • et al.
        Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.
        Science. 2000; 290: 1771-1775
        • Patel S.B.
        • Salen G.
        • Hidada H.
        • et al.
        Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21.
        J Clin Invest. 1998; 102: 1041-1044